top of page

Nicole's Take: Microneedling With Diluted Botox(OnabotulinumtoxinA)

Aug 18
3 min read

Microneedling With Diluted Botox for Skin Rejuvenation


Nicole's Take: This is one of the treatments I'm most excited about — and I want to

explain exactly why, while also being completely transparent about where the

research stands.


Most people think of Botox as a wrinkle-relaxer that freezes muscles. But when you

dilute it and deliver it into the skin itself (not the muscle) using microneedling, it does

something completely different: it improves the actual quality of your skin — texture,

pore size, oiliness, fine lines, tightness, and even redness. Think of it this way:

traditional Botox treats specific wrinkles; microneedling with diluted Botox

treats the skin itself.


The research we've reviewed — 15 studies spanning over 1,900 documented cases

— is overwhelmingly positive. Every single study showed improvement, and not a

single one reported serious side effects. Here's what stands out to me:


For skin texture, pores, and oil control: The largest quantitative study (62

patients) showed significant, measurable improvement in skin texture, roughness,

and pore size at 90 days. Oil production was reduced at every time point measured

— 1 week, 1 month, 2 months, and 3 months — with 91% of patients reporting

50–75% improvement in oiliness. Pore size decreased by 7%, skin lines decreased

by 10%, and pigmentation decreased by 9%. Peak results occur at about 4 weeks,

with benefits lasting at least 3 months.


For the lower face and neck: One study directly compared microbotox to the well-

known "Nefertiti lift" technique — and microbotox was actually more effective for

improving jowls and neck fullness, with 100% patient satisfaction. This is the study

that convinced me this technique offers something traditional Botox simply cannot.

For facial redness and rosacea: Two gold-standard double-blind, placebo-

controlled trials (the highest quality research design) confirmed that intradermal

Botox significantly reduces facial redness compared to placebo — with a 44%

reduction in redness severity in one study. One trial even showed it reduces the

density of visible blood vessels under the skin.


Where I want to be honest with you: While the results are consistently positive,

most of the studies are small (12–62 patients), and many don't have a control group.

We have only 2 double-blind placebo-controlled trials, and those focused specifically

on rosacea, not general skin rejuvenation. The microneedling delivery method

specifically has been tested in only 4 clinical studies — the rest used intradermal

injection, which delivers the Botox to the same skin layer but through a different

technique. The science tells us the mechanism is the same, but more studies using

microneedling specifically would strengthen the evidence. There is also no

standardized protocol yet — dosing, dilution, and treatment intervals vary between

practitioners.


My bottom line: The science behind this treatment is genuinely compelling. The

biological mechanisms are well understood, the results are consistently positive

across every study, the safety profile is excellent, and the real-world clinical

experience (1,867+ documented cases from a single expert alone) confirms what the

research shows. This is not a treatment based on hype — it's based on a growing

body of evidence that Botox does far more than relax muscles. I offer this treatment

with confidence, and I expect the evidence to only get stronger as more clinical trials

are completed.


Key stats: 15 studies reviewed | 1,900+ documented cases | 100% of studies

showed positive results | 91% patient satisfaction for oil reduction | 7% pore size

reduction | 10% reduction in skin lines | 44% reduction in facial redness (placebo-

controlled) | 100% patient satisfaction for lower face/neck | Results last at least 3

months | 0 serious side effects reported | Evidence strength: Moderate-to-Strong —

consistently positive results, but larger controlled trials are still needed

Comments


bottom of page